A3P Biomedical
PrivateLast Round
Private Placement
May 5, 2022
Est. Valuation
$120.84M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
A3P Biomedical is a medical technology company that develops diagnostic tests for the early detection of prostate cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
A3P Biomedical Comparables
Compare A3P Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MDxHealth | 80% | |
| OPKO Health | 78% | |
| Onconetix, Inc. | 76% |
A3P Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | May 5, 2022 | ||||
| Private Placement | Oct 21, 2020 |
A3P Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inbox Capital | Private Placement |
| TomEnterprise | Private Placement |
| Stena Sessan | Private Placement |
| The Foundation for Baltic and East European Studies | Private Placement |
| Flerie AB | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 43% MoM.
- Apr 5, 2026
Monthly visitors increased 794% MoM.
A3P Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about A3P Biomedical's valuation, stock price, and market status.
Is A3P Biomedical a public or private company?
A3P Biomedical is a private company.
What is the current stock price of A3P Biomedical?
A3P Biomedical is a private company with no public stock price. No recent secondary market data is available.
How much is A3P Biomedical worth (valuation)?
A3P Biomedical's valuation is estimated at $120.8M based on funding round data.
Can I buy A3P Biomedical stock?
A3P Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was A3P Biomedical's last funding round?
A3P Biomedical's most recent funding round was Private Placement on May 5, 2022.
Who are the main investors in A3P Biomedical?
Key investors in A3P Biomedical include Inbox Capital, TomEnterprise, Stena Sessan, The Foundation for Baltic and East European Studies, Flerie AB.
Will A3P Biomedical IPO soon?
No public IPO plans have been announced for A3P Biomedical.
How can I track A3P Biomedical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor A3P Biomedical's secondary market activity and sign up for updates.